Co-Diagnostics Past Earnings Performance

Past criteria checks 2/6

Co-Diagnostics has been growing earnings at an average annual rate of 64.5%, while the Medical Equipment industry saw earnings growing at 4.2% annually. Revenues have been growing at an average rate of 71.7% per year. Co-Diagnostics's return on equity is 19.4%, and it has net margins of 35.8%.

Key information

64.5%

Earnings growth rate

62.2%

EPS growth rate

Medical Equipment Industry Growth4.3%
Revenue growth rate71.7%
Return on equity19.4%
Net Margin35.8%
Next Earnings Update10 Nov 2022

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown
Beta

How Co-Diagnostics makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

MUN:C97 Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 2278282216
31 Mar 22101402617
31 Dec 2198372515
30 Sep 21105422514
30 Jun 219646219
31 Mar 219351155
31 Dec 207542133
30 Sep 20482892
30 Jun 20261072
31 Mar 202-651
31 Dec 190-651
30 Sep 190-651
30 Jun 190-651
31 Mar 190-651
31 Dec 180-651
30 Sep 180-651
30 Jun 180-851
31 Mar 180-841
31 Dec 170-741
30 Sep 170-631
30 Jun 170-311
31 Mar 170-211
31 Dec 160-211
30 Sep 160-211
31 Dec 150-211

Quality Earnings: C97 has high quality earnings.

Growing Profit Margin: C97's current net profit margins (35.8%) are lower than last year (48%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: C97 has become profitable over the past 5 years, growing earnings by 64.5% per year.

Accelerating Growth: C97's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: C97 had negative earnings growth (-39.4%) over the past year, making it difficult to compare to the Medical Equipment industry average (3.3%).


Return on Equity

High ROE: C97's Return on Equity (19.4%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.